Afisarea articolelor 1-12(16) pentru indicele czu "54:615.12"
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
Скрининг потенциальных гепатопротекторов в ряду солеподобных аналогов ксимедона |
CZU : 54:615.12+615.2 |
Выштакалюк А., Семенов В., Парфенов А., Гумарова Л., Кондрашина Д., Хасаншина Л., Беляев Г., Диабанкана Р., Назаров Н., Повышева Т., Галяметдинова И., Зобов В. |
Neuroscience for medicine and psychology XIV International interdisciplinary congress |
2018. Moscova, Rusia. ISBN 978-5-317-05830-2. |
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
Screening toxicologic asupra unui nou compus antimicobacterian, derivat al 5-aril-2-tio-1,3,4-oxadiazolului |
CZU : 54:615.12 |
Nicolescu Florica, Uncu Andrei, Ancuceanu Robert, Uncu Livia, Ioniță-Mîndrican Corina Bianca, Macaev Fliur, Negreş Simona, Valica Vladimir |
Revista Farmaceutică a Moldovei |
Nr. 3-4 / 2014 / ISSN 1812-5077 |
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------------------------------------